SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-20-041439
Filing Date
2020-08-27
Accepted
2020-08-27 08:00:17
Documents
12
Period of Report
2020-08-26
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K reta-8k_20200826.htm   iXBRL 8-K 33787
  Complete submission text file 0001564590-20-041439.txt   158661

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA reta-20200826.xsd EX-101.SCH 5772
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE reta-20200826_lab.xml EX-101.LAB 18734
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE reta-20200826_pre.xml EX-101.PRE 11172
5 EXTRACTED XBRL INSTANCE DOCUMENT reta-8k_20200826_htm.xml XML 3428
Mailing Address 5320 LEGACY DRIVE PLANO TX 75024
Business Address 5320 LEGACY DRIVE PLANO TX 75024 972-865-2219
REATA PHARMACEUTICALS INC (Filer) CIK: 0001358762 (see all company filings)

IRS No.: 113651945 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37785 | Film No.: 201139059
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences